Your session is about to expire
← Back to Search
Mango for Cardiovascular Risk
N/A
Waitlist Available
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Women: lack of menses for at least one year and FSH 23-116.3 mlU/mL
Subject is willing and able to comply with the study protocols.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 2 hours compared on days 0 14 and 28
Awards & highlights
Study Summary
This trial will study the effects of mango intake on vascular and platelet function in postmenopausal women.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline to 2 hours compared on days 0 14 and 28
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 2 hours compared on days 0 14 and 28
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acute vascular function
Long-term vascular function
Secondary outcome measures
Acute platelet aggregation
Long-term platelet aggregation
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: 330 grams of daily mango intakeExperimental Treatment1 Intervention
330 grams (2 cups) of daily mango intake for two weeks
Group II: No mango intakePlacebo Group1 Intervention
No mango intake for two weeks
Find a Location
Who is running the clinical trial?
University of California, DavisLead Sponsor
908 Previous Clinical Trials
4,704,094 Total Patients Enrolled
4 Trials studying Cardiovascular Risk
165 Patients Enrolled for Cardiovascular Risk
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger